Affiliations
PROFESSIONAL AFFILIATIONS
American Society of Addiction Medicine 2005 – Present
Distinguished Fellow (DFASAM) 2019 – Present
Immediate Past President 2019 – Present
President 2017 – 2019
President-Elect 2015 – 2017
Director 2011 – Present
Vice Chair of COVID-19 Task Force 2020 – Present
Other roles: Director, Chair of Finance Committee, Chair of Legislative Action Committee, Chair of Public Policy Council, Member of Patient Advocacy Task Force, Membership Committee, Chapters Committee, Parity Committees, Pain and Addiction Committee, Pharmacological Issues Workgroup, Utilization Review Accreditation Liaison
Kentucky Society of Addiction Medicine 2011 – Present
Immediate Past President 2012 – 2014
President 2011 – 2012
Chair of Public Policy Committee 2011 – 2018
American Psychiatric Association (APA) 1988 – Present
Distinguished Fellow (DFAPA) 2011 – Present
Member Integration Work Group 2012 – 2017
American Medical Association 2004 – Present
Member ASAM Delegation to AMA 2016 – Present
Kentucky Medical Association 2015 – Present
Delegate from Greater Louisville Medical Society 2015 – Present
Member Annual Meeting Reference Committee 2016
International Society of Addiction Medicine 2011 – Present
Kentuckiana Health Collaborative 2018 – Present
Contributing member and Consultant on Opioid Toolkit
Member, Finance Committee
Member of Addiction in the Workplace Group
American Association for Physician Leadership /American College of Physician Executives 2006 – Present
American Academy of Addiction Psychiatry 2012 – 2014
Member Public Policy Committee
New York State Psychiatric Association Capital District Branch 2009 – 2012
President-Elect 2012
Secretary 2011 – 2012
Executive Committee Liaison for Payment Strategies
TASK FORCES | EXPERT PANELS | WRITING GROUPS
National Academy of Medicine 2018 – Present
Action Collaborative on Countering the U.S. Opioid Epidemic
Steering Committee Member
Research, Data, and Metrics Working Group Co-Lead
Prevention, Treatment, and Recovery Working Group Member
World Health Organization 2019
Sixth Meeting on the Public Health Implications of Addictive Behavior
Official Observer, Abu Dhabi, UAE
World Health Organization 2019
Regional Capacity Building Workshop for Management and Care of Substance Use Disorders:
Eastern Mediterranean Region Temporary Expert Status
Abu Dhabi, UAE
Milken Institute 2019 – Present
Public Health Advisory Committee Member
National Rx Drug Abuse Summit 2012 – Present
Advisory Board Member
Association of Managed Care Pharmacies 2015 – 2018
Member of Addiction Treatment Action Group
The Council of State Governments Justice Center 2017 – Present
Judges’ and Psychiatrists’ Leadership Initiative, New York, NY
Convening on Behavioral Health Systems of Care and Conditions of Release
National Safety Council: Prescription Drug Overdose Initiative, Arlington, VA 2016
Prescription Drug Expert Panel
Comptroller General’s Forum: Preventing the use of Illicit Drugs and Abuse of Prescription Drugs 2016
Participant. Washington, DC
Johns Hopkins Bloomberg School of Public Health 2015
“The Prescriptions Opioid Epidemic: An Evidence-Based Approach”
Member, Treatment Section Writing Committee
United States Department of Health and Human Services, Rockville, MD 2014
Substance Abuse and Mental Health Services Administration Buprenorphine Summit
Moderator and participant of work group “Addressing Health Systems and Reimbursement.”
Collaborative Care Research Network, American Academy of Family Practice 2011 – 2014
Steering Committee Member
New York State Office of Alcohol and Substance Abuse Services Medical Advisory Panel 2012
Panel Member
Patient Centered Primary Care Collaborative 2010 – 2012
Behavioral Health Task Force Member
Alliance of Community Health Plan Behavioral Health Medical Directors Network 2009 – 2012